Chimerix, Inc. (CMRX) financial statements (2022 and earlier)

Company profile

Business Address 2505 MERIDIAN PARKWAY, SUITE 100
DURHAM, NC 27713
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments88,36778,962113,475186,568151,520232,021220,334
Cash and cash equivalents15,39746,98916,90181,10618,54851,46320,605
Short-term investments72,97031,97396,574105,462132,972180,558199,729
Receivables 3401,2333301,6821,5992,432
Inventory, net of allowances, customer advances and progress billings2,760      
Inventory2,760      
Prepaid expense450354344382481389385
Other current assets2,1547311,7828861,111841851
Other undisclosed current assets2,0741,2711,2591,2921,7391,6154,835
Total current assets:95,80581,658118,093189,458156,533236,465228,837
Noncurrent Assets
Operating lease, right-of-use asset2,4042,825709
Property, plant and equipment2532145401,2101,8942,8433,045
Long-term investments and receivables2,022   76,73147,407124,040
Long-term investments2,022   76,73147,407124,040
Other noncurrent assets56263446725570
Total noncurrent assets:4,7353,0651,2831,25678,69750,305127,155
TOTAL ASSETS:100,54084,723119,376190,714235,230286,770355,992
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,8968,5339,22812,96613,19610,10520,179
Accounts payable2,7881,2832,3984,6913,8123,89010,458
Accrued liabilities13,1087,2506,8308,2759,3846,2159,721
Debt14,000      
Total current liabilities:29,8968,5339,22812,96613,19610,10520,179
Noncurrent Liabilities
Long-term debt and lease obligation2,3922,814     
Operating lease, liability2,3922,814 
Liabilities, other than long-term debt  196144224441354
Deferred revenue and credits 441 
Other liabilities  196144224 354
Other undisclosed noncurrent liabilities(2,392)(2,814)     
Total noncurrent liabilities:2,3922,814196144224441354
Total liabilities:32,28811,3479,42413,11013,42010,54620,533
Stockholders' equity
Stockholders' equity attributable to parent, including:68,25273,376109,952177,604221,810276,224335,459
Additional paid in capital953,782785,673778,693733,907709,514692,422675,591
Accumulated other comprehensive income (loss)(21) 35(92)(963)(440)(764)
Accumulated deficit(885,596)(712,360)(668,838)(556,262)(486,788)(415,804)(339,414)
Other undisclosed stockholders' equity attributable to parent87636251474646
Total stockholders' equity:68,25273,376109,952177,604221,810276,224335,459
TOTAL LIABILITIES AND EQUITY:100,54084,723119,376190,714235,230286,770355,992

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,9795,37212,5197,2164,4945,70210,762
Revenue, net4,4945,70210,762
Gross profit:1,9795,37212,5197,2164,4945,70210,762
Operating expenses(175,379)(49,888)(128,502)(78,821)(76,596)(83,654)(129,013)
Operating loss:(173,400)(44,516)(115,983)(71,605)(72,102)(77,952)(118,251)
Interest and debt expense      (64)
Loss before gain (loss) on sale of properties:(173,400)(44,516)(115,983)(71,605)(72,102)(77,952)(118,315)
Other undisclosed net income 9943,4072,1311,1181,562943
Net loss:(173,400)(43,522)(112,576)(69,474)(70,984)(76,390)(117,372)
Other undisclosed net income attributable to parent164      
Net loss available to common stockholders, diluted:(173,236)(43,522)(112,576)(69,474)(70,984)(76,390)(117,372)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(173,400)(43,522)(112,576)(69,474)(70,984)(76,390)(117,372)
Other comprehensive loss      (118,171)
Comprehensive loss:(173,400)(43,522)(112,576)(69,474)(70,984)(76,390)(235,543)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent143(35)127871(523)324 
Comprehensive loss, net of tax, attributable to parent:(173,257)(43,557)(112,449)(68,603)(71,507)(76,066)(235,543)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: